- Home
- ACET vs SKLZ Comparison
ACET vs SKLZ Comparison
Compare ACET & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- SKLZ
- Stock Information
- Founded
- ACET 1947
- SKLZ 2012
- Country
- ACET United States
- SKLZ United States
- Employees
- ACET N/A
- SKLZ N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- SKLZ EDP Services
- Sector
- ACET Health Care
- SKLZ Technology
- Exchange
- ACET Nasdaq
- SKLZ Nasdaq
- Market Cap
- ACET 111.9M
- SKLZ 102.4M
- IPO Year
- ACET N/A
- SKLZ N/A
- Fundamental
- Price
- ACET $0.64
- SKLZ $6.20
- Analyst Decision
- ACET Buy
- SKLZ Buy
- Analyst Count
- ACET 4
- SKLZ 1
- Target Price
- ACET $8.50
- SKLZ $14.00
- AVG Volume (30 Days)
- ACET 2.2M
- SKLZ 68.4K
- Earning Date
- ACET 11-05-2025
- SKLZ 11-06-2025
- Dividend Yield
- ACET N/A
- SKLZ N/A
- EPS Growth
- ACET N/A
- SKLZ N/A
- EPS
- ACET N/A
- SKLZ N/A
- Revenue
- ACET N/A
- SKLZ $94,857,000.00
- Revenue This Year
- ACET N/A
- SKLZ $17.44
- Revenue Next Year
- ACET N/A
- SKLZ $12.03
- P/E Ratio
- ACET N/A
- SKLZ N/A
- Revenue Growth
- ACET N/A
- SKLZ N/A
- 52 Week Low
- ACET $0.45
- SKLZ $3.54
- 52 Week High
- ACET $1.40
- SKLZ $9.11
- Technical
- Relative Strength Index (RSI)
- ACET 31.44
- SKLZ 34.79
- Support Level
- ACET $0.66
- SKLZ $5.66
- Resistance Level
- ACET $0.71
- SKLZ $6.79
- Average True Range (ATR)
- ACET 0.07
- SKLZ 0.47
- MACD
- ACET -0.03
- SKLZ -0.08
- Stochastic Oscillator
- ACET 7.83
- SKLZ 30.14
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About SKLZ Skillz Inc.
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.